Jump to content
RemedySpot.com

Xolair (Omalizumab) shows promise

Rate this topic


Guest guest

Recommended Posts

Xolair (Omalizumab) shows promise in treating allergic asthma

inadequately controlled by inhaled corticosteroid

Data presented today at the American College of Allergy, Asthma &

Immunology (ACAAI) show that Xolair (Omalizumab) for Subcutaneous Use

significantly reduced asthma attacks in children aged six through 11

with moderate or severe persistent allergic asthma inadequately

controlled with inhaled corticosteroids.

http://www.news-medical.net/?id=42667

Alana

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...